ISIS Voice Present at the AMA House of Delegates Meeting
Thursday, June 27, 2013
Tibiletti, MD and Andrew Yu, MD represented ISIS at the AMA House of Delegates
Annual Meeting June 15-19, 2013. Some of
the key policies that were passed at the meeting were:
· Scope of Practice
Comprehensive guidelines on the definition of invasive pain management
procedures for the treatment of chronic pain – this was an addition to
previously passed policy, which stated that the AMA should actively advocate
that interventional chronic pain management is within the practice of medicine
and should be performed only by physicians.
· Compounding Pharmacies
Comprehensive policy on compounding pharmacies, including a
provision that the AMA supports the view that facilities (other than pharmacies
within a health system) that compound sterile drug products without receiving a
prescription prior to beginning compounding to be recognized as compounding
manufacturers subject to FDA oversight and regulation.
· Drug Shortages
In addition to current policies and a comprehensive report
on drug shortages which is developed annually, the AMA HOD voted on a provision
to advocate for government stockpiling of oral and intravenous parenteral drug
shortage products, or for removal of government policy price controls to
mitigate against an unfair manufacturing free marketplace. The AMA will also develop a webpage resource
dedicated to drug shortages and continue to evaluate the drug shortage issue.